Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' reply

Lancet. 2026 Apr 4;407(10536):1334. doi: 10.1016/S0140-6736(26)00294-1.

Authors

Fei Liang¹, Shaolai Zhou¹, Zheng Wang¹, Jia Fan¹, Jian Zhou²; CARES-009 investigators

Affiliations

¹ Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
² Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: zhou.jian@zs-hospital.sh.cn.

PMID: 41936366
DOI: 10.1016/S0140-6736(26)00294-1

No abstract available

Publication types

Letter